COGT - Cogent Biosciences, Inc. -  [ ]

Ticker Details
Cogent Biosciences, Inc.
IPO Date: March 26, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $5.73B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.31 | 3.14%
Avg Daily Range (30 D): $0.87 | 2.33%
Avg Daily Range (90 D): $0.81 | 2.52%
Institutional Daily Volume
Avg Daily Volume: .7M
Avg Daily Volume (30 D): 1.68M
Avg Daily Volume (90 D): 2.47M
Trade Size
Avg Trade Size (Sh.): 103
Avg Trade Size (Sh.) (30 D): 69
Avg Trade Size (Sh.) (90 D): 80
Institutional Trades
Total Institutional Trades: 2,534
Avg Institutional Trade: $2M
Avg Institutional Trade (30 D): $3.32M
Avg Institutional Trade (90 D): $2.77M
Avg Institutional Trade Volume: .15M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.75M
Avg Closing Trade (30 D): $8.37M
Avg Closing Trade (90 D): $10.59M
Avg Closing Volume: 206.52K
 
News
Feb 10, 2026 @ 1:00 PM
Cogent Biosciences Announces Multiple SUMMIT Poste...
Source: Not Specified
Jan 26, 2026 @ 3:06 PM
Cogent's New Stomach Cancer Treatment Cuts Progres...
Source: Vandana Singh
Jan 6, 2026 @ 1:00 PM
Cogent Biosciences Announces Presentation at the 4...
Source: Na
Dec 6, 2025 @ 2:30 PM
Cogent Biosciences Presents Full SUMMIT Results...
Source: Cogent Biosciences
Nov 14, 2025 @ 1:00 PM
Cogent Biosciences Announces Participation in the ...
Source: Christi Waarich
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-2.16 $-.61 $-2.16
Diluted EPS $-2.16 $-.61 $-2.16
Revenue $M $M $M
Gross Profit
Net Income / Loss $-328.94M $-102.49M $-328.94M
Operating Income / Loss $-333.36M $-99.49M $-333.36M
Cost of Revenue
Net Cash Flow $214.26M $186.8M $214.26M
PE Ratio    
Splits
Nov 09, 2020 1:4